• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Alexza Pharmaceuticals Inc

+ Add to Watchlist

ALXA:US

4.6000 USD 0.1600 3.60%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Alexza Pharmaceuticals Inc (ALXA)

Open: 4.4500 Day's Range: 4.3325 - 4.8800 Volume: 407,140
Previous Close: 4.4400 52wk Range: 3.9200 - 5.9300 1-Yr Rtn: +3.14%

Stock Chart for ALXA

No chart data available.
  • ALXA:US 4.6000
  • 1D
  • 1M
  • 1Y
4.4400
Interactive ALXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALXA

Current P/E Ratio (ttm) 51.1111
Estimated P/E(12/2014) -
Relative P/E vs. SPX 2.8387
Earnings Per Share (USD) (ttm) 0.0900
Est. EPS (USD) (12/2014) -2.2300
Est. PEG Ratio -
Market Cap (M USD) 79.67
Shares Outstanding (M) 17.32
30 Day Average Volume 56,726
Price/Book (mrq) -
Price/Sale (ttm) 1.5376
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALXA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALXA

Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions.

Thomas B KingPresident/CEORobert A LippeExec VP:Operations/COO
James V CassellaExec VP:Research & DevMark K OkiSenior VP:Finance/CFO/Secy
More Company Profile & Key Executives for ALXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil